PacificHealth Laboratories Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. PacificHealth Laboratories recent Real Value cannot be determined due to lack of data. The prevailing price of PacificHealth Laboratories is $0.0. Our model determines the value of PacificHealth Laboratories from analyzing the company fundamentals such as Operating Margin of (0.14) %, return on equity of -0.75, and Shares Outstanding of 20.87 M as well as examining its technical indicators and probability of bankruptcy.
PacificHealth Laboratories Total Value Analysis
PacificHealth Laboratories is at this time expected to have valuation of 571.89 K with market capitalization of 87, debt of 54.86 K, and cash on hands of 324.48 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PacificHealth Laboratories fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
571.89 K | 87 | 54.86 K | 324.48 K |
PacificHealth Laboratories Investor Information
The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PacificHealth Laboratories recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Based on the key indicators related to PacificHealth Laboratories' liquidity, profitability, solvency, and operating efficiency, PacificHealth Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.PacificHealth Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PacificHealth Laboratories has an asset utilization ratio of 365.71 percent. This signifies that the Company is making $3.66 for each dollar of assets. An increasing asset utilization means that PacificHealth Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.PacificHealth Laboratories Profitability Analysis
The company reported the previous year's revenue of 6.91 M. Net Loss for the year was (486.31 K) with profit before overhead, payroll, taxes, and interest of 2.99 M.PacificHealth Laboratories Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Retained Earnings | -20.1 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |